Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Sensory Characteristics and Psychosocial Factors Related With Non-specific Neck Musculoskeletal Pain Chronification (CNSNP)

22 stycznia 2021 zaktualizowane przez: Pablo Herrero Gallego, Universidad San Jorge
Chronic pain is commonly defined as any pain which lasts more than 12 weeks. Chronic non-specific neck pain (CNSNP) has no specific underlying disease causing the pain. There are neurophysiological factors that may modulate pain response and perception in the central nervous system, producing sensory changes such as the presence of temporal summation (TS) and pressure, cold or heat hyperalgesia. TS describes the progressive increase in reported pain intensity as a function of repeated noxious stimulation (e.g. thermal, electrical or mechanical). TS and hyperalgesia are measured through quantitative sensory tests (QST) where pain pressure thresholds (PPT) are measured with an algometer. The current evidence show that PPTs are significantly lower compared to healthy subjects and the association between PPTs, pain intensity and disability are inconsistent. Further, there are psychosocial factors (catastrophizing, kinesiophobia, stress…) that may influence the pain experience. This psychosocial factors associated with chronic pain are not systematically collected in the QST literature complicating the interpretation of data. The objectives of this study are 1) to determine disability, sensory (TS and PPTs) and psychosocial changes (kinesiophobia, catastrophizing, sleep quality, life quality, stress and anxiety) in the natural evolution or in the result of physiotherapy treatment in CNSNP individuals, 2) to study the correlations between disability, psychosocial and sensory factors and 3) to observe if there is a homogeneity between the subjects.

Przegląd badań

Status

Zakończony

Warunki

Typ studiów

Obserwacyjny

Zapisy (Rzeczywisty)

68

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

      • Zaragoza, Hiszpania, 50009
        • Hospital General de la Defensa

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 65 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Metoda próbkowania

Próbka bez prawdopodobieństwa

Badana populacja

The study was divided into 2 groups: individuals with Chronic Non-Specific Neck Pain and healthy controls.

Opis

Inclusion criteria for individuals with CNSNP were:

  1. age between 18 and 65 years;
  2. capable to understand, write, and speak in Spanish;
  3. having suffered neck pain during the last 12 weeks at least;
  4. pain localized in the neck region with or without pain radiation;
  5. Negative Spurling test;
  6. Negative Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS);
  7. Negative Upper Limb Tension Test for the median nerve;
  8. PainDetect test with non-neuropathic pain result. .

Exclusion Criteria:

  1. Presence of red flag as reported in the medical history (i.e. tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis);
  2. Neck pain with cervical radiculopathy;
  3. fibromyalgia syndrome,
  4. previous neck surgery;
  5. currently undergoing any type of pain treatment or having received physical therapy in the previous 3 months.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

Kohorty i interwencje

Grupa / Kohorta
Interwencja / Leczenie
Chronic Non-Specific Neck Pain
Patients with chronic non-specific neck pain. No interventions
Observational study
Control/Healthy Group
Volunteers without pain. No interventions.
Observational study

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Neck Disability Index Change
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
It is a 10-item questionnaire that measures a patient's self-reported neck pain related disability. Questions include activities of daily living, such as: personal care, lifting, reading, work, driving, sleeping, recreational activities, pain intensity, concentration and headache. The 10 item scores are then summed to yield a global NDI score, which has a range of 0-50 where higher values reflect greater neck disability. 1 and 6-month results were subtracted from baseline. As such, positive change scores for neck disability indicate improvement
T0 (baseline); T1 (1 month); T2 (6 months).
Quick-DASH change
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
The purpose of the QuickDASH is to use 11 items to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb. The QuickDASH is a widely used reference of self reported disability. The 11 item scores are then summed to yield a global QuickDASH score, which has a range of 11-100 where higher values reflect greater shoulder/arm disability. 1 and 6-month results were subtracted from baseline. As such, positive change scores for shoulder/arm disability indicate improvement
T0 (baseline); T1 (1 month); T2 (6 months).

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Pressure Pain Threshold change
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
Pressure pain threshold (PPT) is defined as the minimum force applied which induces pain. This measure has proven to be commonly useful in evaluating tenderness symptom.
T0 (baseline); T1 (1 month); T2 (6 months).
Temporal Summation change
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
Temporal summation is a clinical measure of central sensitization in which a high frequency of action potentials in the presynaptic neuron elicits postsynaptic potentials that overlap and summate with each other.
T0 (baseline); T1 (1 month); T2 (6 months).
Area of pain assessed by bodycharts change
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
Participants have to draw on a tablet-based digital body chart (NavigatePain©, Aalborg University, Aalborg, Denmark) the body region in which they felt pain more frequently during the previous month. The use of pain drawings has been found to be reliable in chronic low back, neck, shoulder, and arm pain. Digital pain drawings have also been shown reliable, valid and comparable to paper drawings and useful in clinical population. The size of the pain area was extracted and expressed in pixels.
T0 (baseline); T1 (1 month); T2 (6 months).
Pain Intensity change- Visual Analogic Scale
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
Self-perceived neck pain will record using a Visual Analogue Scale (VAS). Participants have to mark on a 10-cm line their average current neck pain between 0 ("no pain") and 10 ("worst possible pain"). The VAS is a reliable and valid measurement of pain
T0 (baseline); T1 (1 month); T2 (6 months).
Pain Duration change
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
Duration of pain in months
T0 (baseline); T1 (1 month); T2 (6 months).
Catastrophism change. Pain Catastrophizing Scale
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
People are asked to indicate the degree to which they have the above thoughts and feelings when they are experiencing pain using the 0 (not at all) to 4 (all the time) scale. A total score is yielded (ranging from 0-52), along with three subscale scores assessing rumination, magnification and helplessness.
T0 (baseline); T1 (1 month); T2 (6 months).
Kinesiophobia change. Tampa Scale for Kinesiophobia
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
Tampa Scale for Kinesiophobia (TSK) The TSK is a 17-item self-report measure of fear of movement and (re)injury. Four of the items are negatively worded and reversed scored (4, 8, 12, and 16). Ratings are summed to yield a total score where higher values reflect greater fear of (re)injury. The 17 item scores are then summed to yield a global TSK score, which has a range of 11-44.
T0 (baseline); T1 (1 month); T2 (6 months).
Quality of Life change. The 5-level EQ-5D version (EQ-5D-5L)
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
The EQ-5D is a frequently used generic quality of life questionnaire, designed by the EuroQoL. The EQ-5D-5L is an instrument widely used to measure and evaluate general health status. The EQ-5D-5L descriptive system describes general health in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels, indicating no problems, slight problems, moderate problems, severe problems, and extreme problems resulting in a total of 3,125 unique health states. Besides, the EQ-5D-5L also includes a visual analogue scale (EQ-VAS), which recorded the patient's self-rated health on a 20 cm vertical, visual analogue scale with endpoints (0; 100) labeled 'the best health you can imagine' and 'the worst health you can imagine'
T0 (baseline); T1 (1 month); T2 (6 months).
Stress change. Perceived Stress Scale
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
he Perceived Stress Scale (PSS) inquire about feelings and thoughts that tap the degree to which respondents find their current life situation unpredictable, uncontrollable and stressful. Respondents indicate how often in the past month they have felt or thought a certain way on a 5-point Likert scale (0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4 = very often). The higher the score the higher the perceived stress is. The 14 item scores are then summed to yield a global PSS score, which has a range of 0-56
T0 (baseline); T1 (1 month); T2 (6 months).
Quality of Sleep change . Pittsburgh Questionnaire
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
PSQI consists of 19 self-rated questions. The 19 self-rated questions asses a wide variety of factors relating to sleep quality, including estimates of sleep duration and latency and of the frequency and severity of specific sleep-related problems. Theses 19 items are grouped into seven component scores, each weighted equally on a 0-3 scale. The seven component scores are then summed to yield a global PSQI score, which has a range of 0-21; higher scores indicate worse sleep quality.
T0 (baseline); T1 (1 month); T2 (6 months).
Anxiety-Depression change. DASS 21.
Ramy czasowe: T0 (baseline); T1 (1 month); T2 (6 months).
The DASS is a self-report measure, designed to assess the unique and unrelated aspects of anxiety and depression, as well as a third construct (termed stress) that assesses the features common to anxiety and depression. The DASS-21 is comprised of three scales, Depression, Anxiety, and Stress, each of which consists of 7 items. The 21 item scores are then summed to yield a global DASS-21 score, which has a range of 0-63
T0 (baseline); T1 (1 month); T2 (6 months).

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

15 kwietnia 2020

Zakończenie podstawowe (Rzeczywisty)

15 grudnia 2020

Ukończenie studiów (Rzeczywisty)

22 stycznia 2021

Daty rejestracji na studia

Pierwszy przesłany

25 marca 2020

Pierwszy przesłany, który spełnia kryteria kontroli jakości

30 marca 2020

Pierwszy wysłany (Rzeczywisty)

1 kwietnia 2020

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

25 stycznia 2021

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

22 stycznia 2021

Ostatnia weryfikacja

1 stycznia 2021

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

NIE

Opis planu IPD

Data will be provided based on request to authors by email to gortego@usj.es

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

3
Subskrybuj